fda decision tirzepatide Grants a New Indication for Obesity Management Compounded Tirzepatide vs Mounjaro/Zepbound: 75%

Your body is already adapting to a new medication

Patients switching from insurance-covered to PlexusDx tirzepatide often experience improved consistency because dosing adjustments never trigger coverage reconsiderations or delay shipments

1 INDICATIONS AND USAGE INDICATIONS & USAGE SECTION ZEPBOUND is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition

Retrieved from Gikonyo, D., Gikonyo, A., Luvayo, D., & Ponoth, P

See Instructions for Use for more information